Source:http://linkedlifedata.com/resource/pubmed/id/16259729
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1-3
|
pubmed:dateCreated |
2005-11-1
|
pubmed:abstractText |
Histamine-producing ECL cells are numerous in the stomach. They express gastrin/CCK2 receptors and respond to gastrin by releasing histamine. Ultrastructurally, they display numerous and very characteristic secretory organelles: granules, secretory vesicles and microvesicles. This paper focuses on the impact of the gastrin/CCK2 receptor on the ultrastructure of the ECL cells. The effects of pharmacological blockade of the receptor are compared with the effects of receptor elimination following selective gene targeting. Long-term administration of powerful gastrin/CCK2 receptor antagonists was found to induce hypotrophy of rat stomach ECL cells with reduced number of granules, secretory vesicles and microvesicles. In gastrin/CCK2 receptor knockout mice ECL cells, i.e., histamine-storing cells with the characteristic ultrastructure of ECL cells, had disappeared from the oxyntic mucosa and been replaced by a novel population of endocrine-like cells. These cells harbored granules and microvesicles, but were devoid of histamine and secretory vesicles. We suggest that the gastrin/CCK2 receptor is important for the proper differentiation of the ECL cells and for maintaining their characteristic ultrastructure.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Benzodiazepines,
http://linkedlifedata.com/resource/pubmed/chemical/Benzodiazepinones,
http://linkedlifedata.com/resource/pubmed/chemical/Phenylurea Compounds,
http://linkedlifedata.com/resource/pubmed/chemical/Receptor, Cholecystokinin B,
http://linkedlifedata.com/resource/pubmed/chemical/YF 476,
http://linkedlifedata.com/resource/pubmed/chemical/YM 022
|
pubmed:status |
MEDLINE
|
pubmed:issn |
0925-4692
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
13
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
75-82
|
pubmed:dateRevised |
2008-11-21
|
pubmed:meshHeading |
pubmed-meshheading:16259729-Animals,
pubmed-meshheading:16259729-Benzodiazepines,
pubmed-meshheading:16259729-Benzodiazepinones,
pubmed-meshheading:16259729-Enterochromaffin-like Cells,
pubmed-meshheading:16259729-Mice,
pubmed-meshheading:16259729-Mice, Knockout,
pubmed-meshheading:16259729-Microscopy, Electron,
pubmed-meshheading:16259729-Organelles,
pubmed-meshheading:16259729-Phenylurea Compounds,
pubmed-meshheading:16259729-Receptor, Cholecystokinin B
|
pubmed:year |
2005
|
pubmed:articleTitle |
Secretory organelles in ECL cells: effects of pharmacological blockade of the gastrin/CCK2 receptor versus its elimination by gene targeting.
|
pubmed:affiliation |
Department of Cancer Research and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway. Chun-Mei.Zhao@ntnu.no
|
pubmed:publicationType |
Journal Article,
Review
|